Fast and accurate high resolution genotyping of complex immune regions is critical to improving transplant outcomes and understanding disease associations.
Scisco Genetics is dedicated to:
• Providing high quality sequence-based genotyping solutions and services for complex immune gene systems, including HLA and Chimerism.
• Enabling Next Generation Sequencing technology in clinical laboratories that support transplant programs.
• Continuous quality improvement in sequencing technology and software analysis tools.
We are a Seattle-based company established in 2006 by Dr. Dan Geraghty, a member of the Fred Hutchinson Cancer Research Center, to build on his research in HLA and KIR immunogenetics. We are accredited by the American Society for Histocompatibility and Immunogenetics (ASHI)—the leading accreditation program for histocompatibility testing laboratories, the Clinical Laboratory Improvement Amendments (CLIA) program, and the Washington State Department of Health.